REGULATION OF CYTOCHROME P450 IID BY ACUTE PHASE MEDIATORS IN C3H/HEJ MICE

被引:40
作者
TRAUTWEIN, C [1 ]
RAMADORI, G [1 ]
GERKEN, G [1 ]
ZUMBUSCHENFELDE, KHM [1 ]
MANNS, M [1 ]
机构
[1] UNIV MAINZ,DEPT MED 1,W-6500 MAINZ,GERMANY
关键词
D O I
10.1016/0006-291X(92)91777-N
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 IID6 is a drug metabolizing enzyme and the major target antigen in LKM-1 antibody positive chronic active hepatitis. The histological hallmark of chronic active hepatitis is a lymphocytic infiltrate in the liver. It is unknown whether and how cytokines produced and secreted by these tissue infiltrating mononuclear cells regulate the cellular expression of cytochrome P450 IID6. To study the effect of interleukin 1, tumor necrosis factor and interleukin 6 on the hepatocellular RNA expression of cytochrome P450 IID, we injected each of the cytokines in C3H HeJ mice. We found a time-dependent suppression of the cytochrome in the liver. Six hours after the intraperitoneal injection of 0,5 μg interleukin 1 beta the specific RNA-expression was reduced to 25% of the original level. A similar reduction was found after the injection of 2 μg tumor necrosis factor alpha. A mild suppression to 65% of the orginal level was seen six hours following the dose of 100 ng interleukin 6. Our studies show how immune mediators can change the expression of an autoantigen. Further studies in the human system are necessary to estimate this regulation for the elimination of drugs and in LKM-1 antibody positive chronic active hepatitis. © 1992.
引用
收藏
页码:617 / 623
页数:7
相关论文
共 24 条
[1]   ANTI LIVER-KIDNEY MICROSOME ANTIBODY RECOGNIZES A 50,000 MOLECULAR-WEIGHT PROTEIN OF THE ENDOPLASMIC-RETICULUM [J].
ALVAREZ, F ;
BERNARD, O ;
HOMBERG, JC ;
KREIBICH, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1231-1236
[2]   HUMAN ANTI-ENDOPLASMIC RETICULUM AUTOANTIBODIES APPEARING IN A DRUG-INDUCED HEPATITIS ARE DIRECTED AGAINST A HUMAN-LIVER CYTOCHROME-P-450 THAT HYDROXYLATES THE DRUG [J].
BEAUNE, P ;
DANSETTE, PM ;
MANSUY, D ;
KIFFEL, L ;
FINCK, M ;
AMAR, C ;
LEROUX, JP ;
HOMBERG, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (02) :551-555
[3]   DEXAMETHASONE MODULATION OF INVIVO EFFECTS OF ENDOTOXIN, TUMOR NECROSIS FACTOR, AND INTERLEUKIN-1 ON LIVER CYTOCHROME-P-450, PLASMA-FIBRINOGEN, AND SERUM IRON [J].
BERTINI, R ;
BIANCHI, M ;
ERROI, A ;
VILLA, P ;
GHEZZI, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 46 (03) :254-262
[4]  
BIRCH HE, 1986, J BIOL CHEM, V261, P8077
[5]   ANTI-LIVER ENDOPLASMIC-RETICULUM AUTOANTIBODIES ARE DIRECTED AGAINST HUMAN CYTOCHROME-P-4501A2 - A SPECIFIC MARKER OF DIHYDRALAZINE-INDUCED HEPATITIS [J].
BOURDI, M ;
LARREY, D ;
NATAF, J ;
BERNUAU, J ;
PESSAYRE, D ;
IWASAKI, M ;
GUENGERICH, FP ;
BEAUNE, PH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1967-1973
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]  
GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0
[8]   CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].
GONZALEZ, FJ ;
SKODA, RC ;
KIMURA, S ;
UMENO, M ;
ZANGER, UM ;
NEBERT, DW ;
GELBOIN, HV ;
HARDWICK, JP ;
MEYER, UA .
NATURE, 1988, 331 (6155) :442-446
[9]   ANTI-LIVER KIDNEY MICROSOME ANTIBODY TYPE-1 RECOGNIZES HUMAN CYTOCHROME-P450 DB1 [J].
GUEGUEN, M ;
YAMAMOTO, AM ;
BERNARD, O ;
ALVAREZ, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 159 (02) :542-547
[10]   SUBDIVISIONS OF IDIOPATHIC AUTOIMMUNE CHRONIC ACTIVE HEPATITIS [J].
MADDREY, WC .
HEPATOLOGY, 1987, 7 (06) :1372-1375